JP2021531246A5 - - Google Patents
Info
- Publication number
- JP2021531246A5 JP2021531246A5 JP2020573032A JP2020573032A JP2021531246A5 JP 2021531246 A5 JP2021531246 A5 JP 2021531246A5 JP 2020573032 A JP2020573032 A JP 2020573032A JP 2020573032 A JP2020573032 A JP 2020573032A JP 2021531246 A5 JP2021531246 A5 JP 2021531246A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- peptide according
- isolated peptide
- amino acid
- proline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023201767A JP7682248B2 (ja) | 2018-07-11 | 2023-11-29 | ペプチド化合物およびその治療的用途 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL260555 | 2018-07-11 | ||
| IL26055518 | 2018-07-11 | ||
| PCT/IL2019/050774 WO2020012478A2 (en) | 2018-07-11 | 2019-07-10 | Peptide compounds and therapeutic uses of same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023201767A Division JP7682248B2 (ja) | 2018-07-11 | 2023-11-29 | ペプチド化合物およびその治療的用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021531246A JP2021531246A (ja) | 2021-11-18 |
| JP2021531246A5 true JP2021531246A5 (enExample) | 2022-07-19 |
| JP7395517B2 JP7395517B2 (ja) | 2023-12-11 |
Family
ID=69141375
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020573032A Active JP7395517B2 (ja) | 2018-07-11 | 2019-07-10 | ペプチド化合物およびその治療的用途 |
| JP2023201767A Active JP7682248B2 (ja) | 2018-07-11 | 2023-11-29 | ペプチド化合物およびその治療的用途 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023201767A Active JP7682248B2 (ja) | 2018-07-11 | 2023-11-29 | ペプチド化合物およびその治療的用途 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US11912790B2 (enExample) |
| EP (2) | EP3820882B1 (enExample) |
| JP (2) | JP7395517B2 (enExample) |
| KR (1) | KR102880543B1 (enExample) |
| CN (1) | CN112351989B (enExample) |
| AU (2) | AU2019300567B2 (enExample) |
| BR (1) | BR112020024748A2 (enExample) |
| CA (1) | CA3100961A1 (enExample) |
| CO (1) | CO2021001290A2 (enExample) |
| EA (1) | EA202190249A1 (enExample) |
| ES (1) | ES3026158T3 (enExample) |
| HR (1) | HRP20250746T1 (enExample) |
| HU (1) | HUE072141T2 (enExample) |
| IL (2) | IL280101B2 (enExample) |
| MX (1) | MX2021000264A (enExample) |
| PL (1) | PL3820882T3 (enExample) |
| RS (1) | RS66946B1 (enExample) |
| SG (1) | SG11202012773QA (enExample) |
| WO (1) | WO2020012478A2 (enExample) |
| ZA (1) | ZA202100587B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL280101B2 (en) | 2018-07-11 | 2025-05-01 | Immunity Pharma Ltd | Peptide compounds and their therapeutic uses |
| IL272074B2 (en) * | 2020-01-15 | 2024-12-01 | Immunity Pharma Ltd | Peptide compounds and methods of treating diseases using same |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154600B (nl) | 1971-02-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen. |
| JPS4843906B1 (enExample) * | 1970-08-11 | 1973-12-21 | ||
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| NL154599B (nl) | 1970-12-28 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking. |
| US3901654A (en) | 1971-06-21 | 1975-08-26 | Biological Developments | Receptor assays of biologically active compounds employing biologically specific receptors |
| US3853987A (en) | 1971-09-01 | 1974-12-10 | W Dreyer | Immunological reagent and radioimmuno assay |
| US3867517A (en) | 1971-12-21 | 1975-02-18 | Abbott Lab | Direct radioimmunoassay for antigens and their antibodies |
| NL171930C (nl) | 1972-05-11 | 1983-06-01 | Akzo Nv | Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen. |
| US3850578A (en) | 1973-03-12 | 1974-11-26 | H Mcconnell | Process for assaying for biologically active molecules |
| US3935074A (en) | 1973-12-17 | 1976-01-27 | Syva Company | Antibody steric hindrance immunoassay with two antibodies |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4034074A (en) | 1974-09-19 | 1977-07-05 | The Board Of Trustees Of Leland Stanford Junior University | Universal reagent 2-site immunoradiometric assay using labelled anti (IgG) |
| US3984533A (en) | 1975-11-13 | 1976-10-05 | General Electric Company | Electrophoretic method of detecting antigen-antibody reaction |
| US4098876A (en) | 1976-10-26 | 1978-07-04 | Corning Glass Works | Reverse sandwich immunoassay |
| US4879219A (en) | 1980-09-19 | 1989-11-07 | General Hospital Corporation | Immunoassay utilizing monoclonal high affinity IgM antibodies |
| US5011771A (en) | 1984-04-12 | 1991-04-30 | The General Hospital Corporation | Multiepitopic immunometric assay |
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
| US5192659A (en) | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
| US5281521A (en) | 1992-07-20 | 1994-01-25 | The Trustees Of The University Of Pennsylvania | Modified avidin-biotin technique |
| WO1997044447A2 (en) * | 1996-05-03 | 1997-11-27 | President And Fellows Of Harvard College | Transcriptional activation system, activators, and uses therefor |
| US6861256B2 (en) * | 1997-05-15 | 2005-03-01 | The General Hospital Corporation | Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
| GB9711148D0 (en) * | 1997-05-31 | 1997-07-23 | Peptide Therapeutics Ltd | Human MAFA |
| EP0928968A1 (en) | 1998-01-12 | 1999-07-14 | Universität Basel | Screening method for apoptosis and necrosis |
| CA2443314C (en) | 2001-04-03 | 2006-03-21 | The Board Of Trustees Of The Leland Stanford Junior University | Method of imaging cell death in vivo |
| US20040204340A1 (en) | 2003-04-11 | 2004-10-14 | Guilford Pharmaceuticals, Inc. | Polyprolyl inhibitors of cyclophilin |
| AU2005276117C1 (en) * | 2004-08-23 | 2013-04-18 | Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science | Peptide inhibitors for mediating stress responses |
| KR20070100832A (ko) * | 2005-02-01 | 2007-10-11 | 아테뉴온, 엘엘씨 | 항혈관신생 ｐｈｓｃｎ 펩티드를 함유하는 조성물 |
| US7704953B2 (en) | 2006-02-17 | 2010-04-27 | Mdrna, Inc. | Phage displayed cell binding peptides |
| BR112012006005A2 (pt) * | 2009-09-17 | 2017-09-19 | Univ Ramot | "peptídeos no tratamento de transtorno associados ao estresse oxidativo" |
| WO2011126882A2 (en) * | 2010-03-30 | 2011-10-13 | American Type Culture Collection | Therapeutic peptides and their derivatives and therapeutic uses thereof |
| EP2593595B1 (en) * | 2010-07-16 | 2020-03-11 | Avantgen, Inc. | Novel peptides and uses thereof |
| PL2655612T3 (pl) * | 2010-12-23 | 2017-12-29 | Shell Internationale Research Maatschappij B.V. | Czynniki uszkadzające geny produkujące pochodne tłuszczowego acylo-coa |
| CA2836503C (en) | 2011-05-23 | 2020-09-22 | Yeda Research And Development Co. Ltd. | Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same |
| US20140271666A1 (en) * | 2013-03-14 | 2014-09-18 | Immune Pharmaceuticals Ltd. | Use of anti-eotaxin antibodies for treating inflammatory bowel disease |
| CN104045703B (zh) * | 2013-03-15 | 2021-04-06 | 深圳君圣泰生物技术有限公司 | 一种多肽、多肽衍生物、多肽的可药用盐及药物组合物 |
| US8802633B1 (en) | 2013-03-18 | 2014-08-12 | Board Of Regents, The University Of Texas System | Autophagy-inducing peptide analogs |
| EP3169343B1 (en) * | 2014-07-15 | 2020-03-25 | Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. | Isolated polypeptides of cd44 and uses thereof |
| US9453061B2 (en) * | 2014-08-06 | 2016-09-27 | Brown University | Method and compositions for treatment of calcineurin-related diseases |
| BR112017022845A2 (pt) | 2015-04-23 | 2018-07-17 | Nantomics, Llc | neoepítopos de câncer |
| WO2017011338A1 (en) | 2015-07-10 | 2017-01-19 | President And Fellows Of Harvard College | Sortase-mediated coupling of immunogenic polysaccharide-protein conjugates and their use |
| IL280101B2 (en) | 2018-07-11 | 2025-05-01 | Immunity Pharma Ltd | Peptide compounds and their therapeutic uses |
| IL272074B2 (en) | 2020-01-15 | 2024-12-01 | Immunity Pharma Ltd | Peptide compounds and methods of treating diseases using same |
-
2019
- 2019-07-10 IL IL280101A patent/IL280101B2/en unknown
- 2019-07-10 SG SG11202012773QA patent/SG11202012773QA/en unknown
- 2019-07-10 RS RS20250622A patent/RS66946B1/sr unknown
- 2019-07-10 IL IL317252A patent/IL317252A/en unknown
- 2019-07-10 MX MX2021000264A patent/MX2021000264A/es unknown
- 2019-07-10 AU AU2019300567A patent/AU2019300567B2/en active Active
- 2019-07-10 EP EP19752749.2A patent/EP3820882B1/en active Active
- 2019-07-10 EA EA202190249A patent/EA202190249A1/ru unknown
- 2019-07-10 BR BR112020024748-0A patent/BR112020024748A2/pt unknown
- 2019-07-10 KR KR1020217004105A patent/KR102880543B1/ko active Active
- 2019-07-10 CN CN201980041027.6A patent/CN112351989B/zh active Active
- 2019-07-10 US US17/254,867 patent/US11912790B2/en active Active
- 2019-07-10 HR HRP20250746TT patent/HRP20250746T1/hr unknown
- 2019-07-10 WO PCT/IL2019/050774 patent/WO2020012478A2/en not_active Ceased
- 2019-07-10 CA CA3100961A patent/CA3100961A1/en active Pending
- 2019-07-10 PL PL19752749.2T patent/PL3820882T3/pl unknown
- 2019-07-10 EP EP25167540.1A patent/EP4566617A3/en active Pending
- 2019-07-10 JP JP2020573032A patent/JP7395517B2/ja active Active
- 2019-07-10 ES ES19752749T patent/ES3026158T3/es active Active
- 2019-07-10 HU HUE19752749A patent/HUE072141T2/hu unknown
-
2021
- 2021-01-27 ZA ZA2021/00587A patent/ZA202100587B/en unknown
- 2021-02-05 CO CONC2021/0001290A patent/CO2021001290A2/es unknown
-
2023
- 2023-11-29 JP JP2023201767A patent/JP7682248B2/ja active Active
-
2024
- 2024-02-26 US US18/586,715 patent/US20240190919A1/en active Pending
- 2024-12-16 AU AU2024278477A patent/AU2024278477A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5688290B2 (ja) | 抗菌性ペプチド | |
| DE60329201D1 (de) | Substituierte wt1-peptide | |
| IL262805B1 (en) | CD47 agonist factors for inducing programmed cell death and their use in the treatment of diseases associated with defects in programmed cell death | |
| JP2020023567A5 (enExample) | ||
| CA2489227A1 (en) | Hla-a24-restricted cancer antigen peptides | |
| CN106232616A (zh) | 两亲性合成抗菌肽、其药物组合物及其用途 | |
| JP2006506942A5 (enExample) | ||
| JP2020507623A5 (enExample) | ||
| JP2007535910A5 (enExample) | ||
| CA1337407C (en) | Dimeric peptides having a stimulatory effect on haemopoiesis and a process for their preparation | |
| JP2021531246A5 (enExample) | ||
| JPWO2021070696A5 (enExample) | ||
| EP2990415B1 (en) | Cyclic beta defensins analogs for the treatment of infections | |
| JP2002539829A5 (enExample) | ||
| CN114080394A (zh) | 新型θ-防御素类似物 | |
| HRP20250746T1 (hr) | Peptidni spojevi i njihova terapijska upotreba | |
| JP2008508363A5 (enExample) | ||
| JP2025511086A5 (enExample) | ||
| RU2021103167A (ru) | Пептидные соединения и их терапевтическое применение | |
| JP2024525959A5 (enExample) | ||
| JP2005500390A5 (enExample) | ||
| RU2024102163A (ru) | Пептидные соединения и их терапевтическое применение | |
| US20200071357A1 (en) | Antimicrobial peptides | |
| JP2023541087A5 (enExample) | ||
| JP2023510019A5 (enExample) |